 |
About Diabetes
Q: What is diabetes?
A:
Diabetes mellitus, a group of diseases characterized by high levels of
blood glucose, results from defects in insulin secretion, insulin action
or both. Diabetes is a disease in which the body does not produce or
properly use insulin, a hormone produced by the pancreas that is needed to
convert sugar, starches and other food into energy needed for daily life.
Digestive juices break down most of the food we eat into glucose, a simple
sugar. Glucose is the main source of fuel for the body. After digestion,
the glucose passes into the bloodstream where it is available for body
cells to use for growth and energy. For the glucose to get into the cells,
insulin must be present. When we eat, the pancreas is supposed to produce
the right amount of insulin automatically to move the glucose from our
blood into our cells. In people with diabetes, however, the pancreas
either produces little or no insulin, or the body's cells do not respond
to the insulin that is produced. As a result, glucose builds up in the
blood, overflows into the urine, and passes out of the body. Thus, the
body loses its main source of fuel even though the blood contains large
amounts of glucose.
|
 | |
 |
|
|
|
Q: What are the different types
of diabetes? A: There are three main types of diabetes: Type 1,
Type 2 and Gestational diabetes.
- Type 1 diabetes (also known as
insulin-dependent diabetes mellitus or juvenile diabetes) is considered
an autoimmune disease. In Type 1 diabetes, the immune system attacks the
insulin-producing beta cells in the pancreas and destroys them. The
pancreas then produces little or no insulin. Someone with Type 1
diabetes needs daily injections of insulin to live. Type 1 diabetes
accounts for about 5-10 percent of diagnosed diabetes in the United
States.
Type 1 diabetes develops most often in children and young
adults, but the disorder can appear at any age. Symptoms of Type 1
diabetes usually develop over a short period and symptoms include
increased thirst and urination, constant hunger, weight loss, blurred
vision, and extreme tiredness. If not diagnosed and treated with
insulin, a person can lapse into a life-threatening coma.
- Type 2 diabetes is the most
common form of diabetes (also known as noninsulin-dependent diabetes
mellitus or NIDDM). About 90-95 percent of people with diabetes have
Type 2 diabetes. This form of diabetes usually develops in adults after
the age of 40 and is most common among adults after age 55. About 80
percent of people with Type 2 diabetes are overweight.
In Type 2
diabetes, the pancreas usually produces insulin, but for some reason,
the body cannot use the insulin effectively. The result is the same as
for Type 1 diabetes - an unhealthy buildup of glucose in the blood and
an inability of the body to make efficient use of its main source of
fuel. The symptoms of Type 2 diabetes develop gradually and are not as
noticeable as in Type 1 diabetes. Symptoms include feeling tired or ill,
frequent urination (especially at night), unusual thirst, weight loss,
blurred vision, frequent infections, and slow healing of sores.
- Gestational diabetes develops
during pregnancy. This type usually disappears when the pregnancy is
over, but women who have had Gestational diabetes have a greater risk of
developing Type 2 diabetes later in their lives.
|
 |
Q: What is the health impact of
diabetes?
A: Diabetes is widely recognized as one of the leading
causes of death and disability in the United States. Diabetes costs the
United States $98 billion in 1997. Indirect costs, including disability
payments, time lost from work, and premature death, totaled $54 billion;
medical costs for diabetes care, including hospitalizations, medical care,
and treatment supplies totaled $44 billion.
|
 |
Q: Who gets diabetes?
A:
There are 17 million people or 5.9% of the U.S. population who have
diabetes. While an estimated 11.5 million have been diagnosed, 5.5
million people are not aware that they have the disease. Type 1
diabetes occurs equally among males and females, but is more common in
whites than in nonwhites. Type 2 diabetes is more common in older
people, especially older women who are overweight, and occurs more often
among African Americans, Hispanics, and American Indians. The prevalence
of diabetes is likely to increase because older people, Hispanics, and
other minority groups make up the fastest growing segments of the U.S.
population.
|
 |
Q: What are the complications of
diabetes?
A: With its complications, diabetes is the seventh
leading cause of death in the United States. Diabetes is the leading cause
of new blindness in people 20-74 years of age. Ten to twenty-one percent
of all people with diabetes develop kidney disease. People with diabetes
are 2-4 times more likely to have heart disease. About 60%-70% of people
with diabetes have mild to severe forms of diabetic nerve damage, which,
in severe forms, can lead to lower limb amputations. Additionally,
impotence afflicts approximately 13% of men who have Type 1 diabetes
and 8% of men who have Type 2 diabetes.
|
 |
Q: How is diabetes
managed?
A: Daily injections of insulin are the basic therapy for
Type 1 diabetes. Insulin injections must be balanced with meals and daily
activities, and glucose levels must be closely monitored through frequent
blood glucose testing. Diet, exercise, and blood testing for glucose are
also the basis for management of Type 2 diabetes. In addition, some people
with Type 2 diabetes take oral drugs or insulin to lower their blood
glucose levels. People with diabetes must take responsibility for their
day-to-day care. Much of the daily care involves trying to keep blood
glucose levels from going too low or too high. When blood glucose levels
drop too low, the condition is known as hypoglycemia. On the other hand, a
person can become very ill if blood glucose levels rise too high, a
condition known as hyperglycemia. Hypoglycemia and hyperglycemia, which
can occur in people with Type 1 diabetes or Type 2 diabetes, are both
potentially life-threatening emergencies. The goal of diabetes management
is to keep blood glucose levels as close as possible to the normal
(nondiabetic) range.
|
 |
Q: What are the DCCT and the
UKPDS?
A 10-year study, called the Diabetes Control and
Complications Trial (DCCT), was completed in 1993 and included
1,441 people with Type 1 diabetes. The study compared the effect
of two treatment approaches - intensive management and standard management
- on the development and progression of eye, kidney, and nerve
complications of diabetes. Researchers found that study participants who
maintained lower levels of blood glucose through intensive management had
significantly lower rates of these complications. Another 10-year study
called the United Kingdom Prospective Diabetes Study (UKPDS) studied
patients with Type 2 diabetes and had similar findings - improved
glycemic status as measured by A1C values translates into reductions in
risk for getting diabetes complications. |
|
|